Clinical Trials Logo

Clinical Trial Summary

Randomized, controlled, double-blind intervention study of four parallel branches depending on the product consumed, to analyze the efficacy of an Omega-3 based product on the mobility and functionality of the evaluated joint.


Clinical Trial Description

The duration of the study will be 60 days (8 weeks). Each day they will have to consume the product under investigation. Subjects who meet the selection criteria will be randomized into each of the study groups (A, B, C o D, depending on the group in which they have been randomized). Each day the subjects will have to fill in a diary regarding pain and concomitant medication. They will make a total of two visits to the research laboratory and will perform the tests pre-established in the protocol. In addition, a follow-up telephone call will be made after 30 days of consume. Subsequently, a statistical analysis will be performed with the variables measured in the study to obtain the results. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05279573
Study type Interventional
Source Universidad Católica San Antonio de Murcia
Contact
Status Completed
Phase N/A
Start date February 14, 2022
Completion date December 23, 2022

See also
  Status Clinical Trial Phase
Completed NCT02124031 - Mexican Initiative of Patients With Osteoarthritis and Rheumatoid Arthritis (IMPACTAR) N/A
Completed NCT04361513 - Genicular Nerve Block in Rheuamtoid Arthritis Phase 4